Quinta-Analytica s.r.o.

Prague 47 trials 2 recruiting

47 Registered trials

2 Currently recruiting

Organisation

Quinta-Analytica s.r.o.

Location

Prague, Czechia

Identifier

ORG-100011570

Address

Umelecka 305/1, Moravska Ostrava, 702 00, Czechia

Departments

Clinic
clinical
Clinical Unit
Clinical Unit of Quinta-Analytica s.r.o
Klinika onkologie a radioterapie
management
N/A
Quinta-Analytica

Clinical trials at this site (47)

Search interface

The pivotal bioequivalence study comparing the test product to the reference product, which belongs to the group of medicines used in treatm… Ended

2025-521400-21-00 Not applicable (submitted trial is a BE study in health 2 2025-05-15
The pivotal bioequivalence study comparing the test product to the reference product, which belong to the group of medicines used in treatme… Ended

2024-518988-35-00 Not applicable (submitted trial is a bioequivalence in 2 2025-04-01
A randomised, open label, single dose, two periods, crossover study of the comparative pharmacokinetics of two alendronic acid formulations … Ended

2024-519666-43-00 not applicable (submitted trial is a pharmacokinetic st 3 2025-03-04
Randomized, open-label, single-dose, two-period, cross-over, bioequivalence study comparing Linagliptin 5 mg film-coated tablets (Vipharm S.… Ended

2024-514678-35-00 Bioequivalence study in healthy volunteers under fastin 2 2024-11-15
An open label, randomized, crossover, two-period, two-sequence, multiple dose study to assess the relative bioavailability of Rotigotine 4.5… Ended

2024-515841-41-00 Not applicable (submitted trial is a bioavailability st 2 2024-11-04
Open-label, randomized, two-treatment, two-period, two-sequence, cross-over, single dose, bioequivalence study comparing ISOPRINOSINE® FORTE… Ended

2024-514146-37-00 not applicable (submitted trial is a bioequivalence stu 2 2024-10-24
An open label, randomized, single dose, two-sequence, two-treatment, four-period, fully replicate, cross-over pharmacokinetic study comparin… Ended

2024-516942-21-00 Not applicable (submitted trial is a bioavailability st 2 2024-10-21
An open label, randomized, two-period, two-sequence, crossover bioavailability study to assess the pharmacokinetic and safety profile of Val… Ended

2024-516184-87-00 not applicable (submitted trial is a bioavailability st 2 2024-10-18
An open label, randomized, crossover, two-period, two-sequence, single dose study to assess the relative bioavailability of Rotigotine 4.5 m… Ended

2024-515840-21-00 Not applicable (submitted trial is a bioavailability st 2 2024-09-30
Ibuprofen 200 mg bioequivalence study Ended

2024-516161-36-00 not applicable (submitted trial is BE) 2 2024-09-13
A Randomized, Single-dose, Crossover, Two-period, Pilot Comparative Bioavailability Study of Alendronate 70 mg effervescent vs. Fosamax 70 m… Ended

2024-513615-26-00 not applicable (submitted trial is a comparative bioava 2 2024-09-12
Randomized, open-label, single dose, two-period, two-treatment, cross-over bioequivalence study comparing test product Rivaroxaban/Acetylsal… Ended

2024-513665-40-00 not applicable (submitted trial is a bioequivalence in 2 2024-06-25
An open label, randomized, two-period, two-sequence, crossover bioavailability study to assess the pharmacokinetic and safety profile of Val… Ended

2024-511570-77-00 not applicable (submitted trial is a bioavailability st 2 2024-05-13
Pharmacokinetic Study of Single and Multiple Dose of PKL-021 Administered Orally to Healthy Subjects Ended

2023-506633-30-00 N/A submitted trial is conducted on healthy subjects 3 2023-10-13
Randomized, open-label, single dose, three-period, three treatment cross-over bioavailability study comparing test products Rosuvastatin/Eze… Ended

2023-507048-35-00 not applicable (submitted trial is bioavailability stud 3 2023-10-11
Randomized, Open-label, Single-Dose, Two-treatment, Two-period, Cross-over, Pivotal Bioequivalence Study Comparing Amoxicilin/Clavulanic aci… Ended

2023-503233-22-00 Not applicable (submitted trial is a bioequivalence stu 2 2023-09-27
An open label, randomized, three-period, three-sequence, crossover bioavailability study to assess the pharmacokinetic and safety profile of… Ended

2023-504760-42-00 Not applicable (submitted trial is a bioequivalence stu 2 2023-09-27
Randomized, open-label, single dose, four-period, cross-over drug-drug interaction study comparing reference products Crestor 20 mg film coa… Ended

2023-505153-41-00 Not applicable (submitted trial is a study in healthy s 3 2023-08-17
Single Dose Crossover Comparative Bioavailability and Food Effect Study of Celecoxib 10 mg/1 mL Oral Suspension versus Celebrex®️ (celecoxib… Ended

2023-504052-99-00 Musculoskeletal and connective tissue disorders, Dysmen 2 2023-07-31
A Phase I study to evaluate the Pharmacokinetics and Safety of Letrozole LEBE in Healthy Post-menopausal Women. Ended

2023-503948-13-00 Healthy Post-menopausal women. 3 2023-07-20
Randomized, open-label, single dose, two-period, cross-over bioequivalence study comparing test formulation Rosuvastatin/Amlodipine/Ramipril… Ended

2023-503822-38-00 Not applicable (submitted trial is a bioequivalence stu 2 2023-06-19
Single dose, open-label, laboratory blinded, randomised, 2-treatment, 2-period, 2-sequence, crossover bioequivalence study of test product P… Ended

2023-504132-18-00 N.A. (submitted trial is a bioequivalence study in heal 2 2023-06-19
Single dose, open-label, laboratory blinded, randomised, 2-treatment, 2-period, 2-sequence, crossover bioequivalence study of test product P… Ended

2023-503345-59-00 Not applicable (submitted trial is a bioequivalence stu 2 2023-05-23